CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials13683
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey12066
Cancer treatment and survivorship statistics, 20258667
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies5093
1896
Issue Information1751
Near majority of adults favor R ratings for films with smoking1471
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer681
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians464
Cancer statistics 2024: All hands on deck427
Most patients with cancer are not undergoing germline genetic testing351
Multicancer detection tests: What we know and what we don’t know288
Current treatment and future directions in the management of anal cancer278
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies272
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types270
More care needed for cancer caregivers268
266
Issue Information233
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial180
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review176
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine158
The evolving landscape of tissue‐agnostic therapies in precision oncology154
Health insurance status and cancer stage at diagnosis and survival in the United States152
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians145
Does distance deter male fertility preservation?142
Medicaid expansion increases survival for patients with cancer135
Study identifies risk factors that may lead to secondary cancers133
Overlooked barriers to implementation of geriatric assessment126
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma112
Lung cancer screening guidelines: Smoking matters, not quitting100
The contemporary management of cancers of the sinonasal tract in adults92
Interventional gastroenterology in oncology85
Cancer survivors at greater risk for bone fractures late in life79
Issue Information70
Screening for lung cancer68
Bilateral mastectomy may not reduce mortality risk68
Issue Information68
From medical student to Editor: A note of thanks66
Breast Cancer Statistics, 202266
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance62
Issue Information59
Prevention of device‐related infections in patients with cancer: Current practice and future horizons59
Clinical management of metastatic colorectal cancer in the era of precision medicine57
American Cancer Society nutrition and physical activity guideline for cancer survivors54
Better communication is key for quality‐of‐life improvement in low‐income and minority patients53
Cancer treatment and survivorship statistics, 202253
53
Issue Information51
Cancer misinformation on social media37
37
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries33
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors33
Key issues face AI deployment in cancer care32
29
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer26
26
Fecal microbiota transplants may aid melanoma immunotherapy resistance26
Social determinants of health and US cancer screening interventions: A systematic review26
Geriatric assessment for the practicing clinician: The why, what, and how25
Radiotheranostics in oncology: Making precision medicine possible24
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach22
Global cancer statistics: A healthy population relies on population health22
Reviewer acknowledgement 202221
Is mandated genetic counseling needed?20
Smoking cessation support lags behind lung cancer screenings19
17
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?16
Carcinoma of unknown primary: Molecular tumor board‐based therapy16
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer15
15
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer15
Cancer disparities for LGBTQ+ patients identified more fully15
Issue Information12
Issue Information11
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer11
The evolving landscape of salivary gland tumors11
Study identifies signs and symptoms of colorectal cancer risk at younger ages11
Issue Information10
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates10
Sustained weight loss may reduce cancer risk10
New studies examine COVID‐19 risks among cancer patients10
American Cancer Society's report on the status of cancer disparities in the United States, 20219
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer9
An overview of real‐world data sources for oncology and considerations for research9
Genomic‐derived radiation dosage improves prediction of outcomes9
Virtual exercise regimens can help patients with cancer8
Issue Information8
7
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians7
7
7
Locally advanced lung cancer7
How can hospitals change practice to better implement smoking cessation interventions? A systematic review7
Modern developments in germline pharmacogenomics for oncology prescribing6
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review6
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy5
Issue Information5
Erratum to “Cancer statistics, 2024”5
MCED blood test boosts cancer detection in symptomatic patients4
Cancer statistics for African American and Black people, 20254
Colon cancer blood test effective for average‐risk population4
Issue Information4
Radiation therapy‐associated toxicity: Etiology, management, and prevention4
Cancer in rural America: Improving access to clinical trials and quality of oncologic care4
4
Erectile dysfunction common within the first year after rectal cancer surgery4
4
Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology4
Most young female cancer survivors are at minimal risk for obstetric problems3
Cancer risk among World Trade Center rescue and recovery workers: A review3
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature3
Breast cancer survivors face greater cardiometabolic risks3
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 20192
People experiencing homelessness face inpatient care disparities2
Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review2
Cancer statistics, 20252
Cancer care for people with dementia: Literature overview and recommendations for practice and research2
Multidisciplinary considerations in the maintenance treatment of poly(ADP‐ribose) polymerase inhibitors for homologous recombination‐proficient, advanced‐stage epithelial ovarian cancer2
Critical care management of chimeric antigen receptor T‐cell therapy recipients2
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer2
2
0.069620132446289